{"transactions":[{"id":4627302,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-28T12:45:19.000Z","date":"2026-09-24","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":2.78,"value":19460.0,"ownership":{"direct":true},"balance_after":672000,"source":{"system":"sec-edgar","filing":"0001493152-26-044458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191905/000149315226044458/ownership.xml","form_type":"4"}},{"id":4616619,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-14T13:45:02.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":2.75,"value":8250.0,"ownership":{"direct":true},"balance_after":665000,"source":{"system":"sec-edgar","filing":"0001493152-26-042512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191905/000149315226042512/ownership.xml","form_type":"4"}},{"id":4615595,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-09-11T12:00:26.000Z","date":"2026-09-10","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":2.76,"value":13800.0,"ownership":{"direct":true},"balance_after":662000,"source":{"system":"sec-edgar","filing":"0001493152-26-042302","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1191905/000149315226042302/ownership.xml","form_type":"4"}},{"id":699463,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-03T08:45:18.000Z","date":"2026-07-31","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.47,"value":17350.0,"ownership":{"direct":true},"balance_after":657000,"source":{"system":"sec-edgar","filing":"0001493152-26-035751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226035751/ownership.xml","form_type":"4"}},{"id":702601,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-28T10:20:30.000Z","date":"2026-07-27","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.44,"value":17200.0,"ownership":{"direct":true},"balance_after":652000,"source":{"system":"sec-edgar","filing":"0001493152-26-034952","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034952/ownership.xml","form_type":"4"}},{"id":703245,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-27T15:25:14.000Z","date":"2026-07-27","kind":"purchase","planned":false,"acquired":true,"shares":3188,"price":3.37,"value":10743.56,"ownership":{"direct":true},"balance_after":647000,"source":{"system":"sec-edgar","filing":"0001493152-26-034772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034772/ownership.xml","form_type":"4"}},{"id":703246,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-27T09:00:29.000Z","date":"2026-07-24","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":3.73,"value":11190.0,"ownership":{"direct":true},"balance_after":643812,"source":{"system":"sec-edgar","filing":"0001493152-26-034723","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034723/ownership.xml","form_type":"4"}},{"id":705400,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-21T10:23:18.000Z","date":"2026-07-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.46,"value":17300.0,"ownership":{"direct":true},"balance_after":640812,"source":{"system":"sec-edgar","filing":"0001493152-26-034027","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226034027/ownership.xml","form_type":"4"}},{"id":710907,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-13T08:59:58.000Z","date":"2026-07-10","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.04,"value":15200.0,"ownership":{"direct":true},"balance_after":635812,"source":{"system":"sec-edgar","filing":"0001493152-26-032961","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226032961/ownership.xml","form_type":"4"}},{"id":737109,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-06-16T09:00:11.000Z","date":"2026-06-12","kind":"purchase","planned":false,"acquired":true,"shares":21000,"price":2.5,"value":52500.0,"ownership":{"direct":true},"balance_after":630812,"source":{"system":"sec-edgar","filing":"0001493152-26-028827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226028827/ownership.xml","form_type":"4"}},{"id":949150,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2026-01-06T19:42:43.000Z","date":"2026-01-05","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026."}],"balance_after":350000,"derivative":{"exercise_price":3.18,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-26-000688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315226000688/ownership.xml","form_type":"4"}},{"id":1011080,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-10-31T09:13:33.000Z","date":"2025-10-30","kind":"exercise","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated February 18, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in 36 consecutive monthly installments beginning on March 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.92,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-25-020322","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225020322/ownership.xml","form_type":"4"}},{"id":1011079,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-31T09:13:33.000Z","date":"2025-10-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":169439,"price":4.06,"value":687922.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person exercised the stock options at this time due to their upcoming expiration on February 18, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options."}],"balance_after":610486,"source":{"system":"sec-edgar","filing":"0001493152-25-020322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225020322/ownership.xml","form_type":"4"}},{"id":1011078,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-31T09:13:33.000Z","date":"2025-10-30","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":2.92,"value":584000.0,"ownership":{"direct":true},"balance_after":779925,"source":{"system":"sec-edgar","filing":"0001493152-25-020322","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225020322/ownership.xml","form_type":"4"}},{"id":1078741,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-31T09:00:04.000Z","date":"2025-07-30","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.16,"value":15800.0,"ownership":{"direct":true},"balance_after":579925,"source":{"system":"sec-edgar","filing":"0001641172-25-021679","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225021679/ownership.xml","form_type":"4"}},{"id":1088310,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-14T08:40:10.000Z","date":"2025-07-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.15,"value":15750.0,"ownership":{"direct":true},"balance_after":574925,"source":{"system":"sec-edgar","filing":"0001641172-25-018898","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225018898/ownership.xml","form_type":"4"}},{"id":1122135,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-05T09:11:56.000Z","date":"2025-06-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":2.85,"value":28500.0,"ownership":{"direct":true},"balance_after":569925,"source":{"system":"sec-edgar","filing":"0001641172-25-013724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000164117225013724/ownership.xml","form_type":"4"}},{"id":1302952,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-15T13:15:32.000Z","date":"2025-01-15","kind":"purchase","planned":false,"acquired":true,"shares":43000,"price":2.23,"value":95890.0,"ownership":{"direct":true},"balance_after":559925,"source":{"system":"sec-edgar","filing":"0001493152-25-002321","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225002321/ownership.xml","form_type":"4"}},{"id":1317636,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2025-01-03T17:40:34.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2025."}],"balance_after":700000,"derivative":{"exercise_price":2.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001493152-25-000316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315225000316/ownership.xml","form_type":"4"}},{"id":1487746,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-06-07T10:57:50.000Z","date":"2024-06-07","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.41,"value":60250.0,"ownership":{"direct":true},"balance_after":516925,"source":{"system":"sec-edgar","filing":"0001493152-24-023023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224023023/ownership.xml","form_type":"4"}},{"id":1575812,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-15T10:49:36.000Z","date":"2024-03-15","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":3.22,"value":96600.0,"ownership":{"direct":true},"balance_after":491925,"source":{"system":"sec-edgar","filing":"0001493152-24-010028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224010028/ownership.xml","form_type":"4"}},{"id":1679557,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-01-16T19:05:55.000Z","date":"2024-01-12","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2024."}],"balance_after":700000,"derivative":{"exercise_price":4.39,"expiration_date":"2034-01-12","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001493152-24-002527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315224002527/ownership.xml","form_type":"4"}},{"id":1821073,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-28","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated November 8, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2013-11-08","expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1821072,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-31","kind":"sale","planned":false,"acquired":false,"shares":11800,"price":3.57,"value":42126.0,"ownership":{"direct":true},"balance_after":461925,"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1821071,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":28375,"price":3.63,"value":103001.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting persons exercised the stock options at this time due to their expiration on November 8, 2023. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to cover the exercise price of the stock options."}],"balance_after":473725,"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":1821070,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-31T18:34:37.000Z","date":"2023-07-28","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":2.575,"value":103000.0,"ownership":{"direct":true},"balance_after":502100,"source":{"system":"sec-edgar","filing":"0001493152-23-026125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223026125/ownership.xml","form_type":"4"}},{"id":2071073,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-04T20:49:49.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2023."}],"balance_after":700000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001493152-23-000417","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315223000417/ownership.xml","form_type":"4"}},{"id":2157995,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-16T17:20:18.000Z","date":"2022-09-15","kind":"exercise","acquired":false,"shares":640000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Right-To-Buy, pursuant to a stock option grant dated September 19, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.575,"exercise_date":"2012-09-19","expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":640000},"source":{"system":"sec-edgar","filing":"0001493152-22-026121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026121/ownership.xml","form_type":"4"}},{"id":2157994,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-16T17:20:18.000Z","date":"2022-09-15","kind":"tax_withholding","acquired":false,"shares":491900,"price":4.48,"value":2203712.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting persons exercised the stock options at this time due to their expiration on September 19, 2022. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the \"registrant\") to (i) cover the exercise price of the stock options and (ii) satisfy tax withholding obligations in connection with the exercise of the stock options. Dr. Kumar did not sell any shares in connection with the exercise of the options."}],"balance_after":462100,"source":{"system":"sec-edgar","filing":"0001493152-22-026121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026121/ownership.xml","form_type":"4"}},{"id":2157993,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-09-16T17:20:18.000Z","date":"2022-09-15","kind":"exercise","acquired":true,"shares":640000,"price":2.575,"value":1648000.0,"ownership":{"direct":true},"balance_after":954000,"source":{"system":"sec-edgar","filing":"0001493152-22-026121","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222026121/ownership.xml","form_type":"4"}},{"id":2338853,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-11T16:15:30.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning March 31, 2022."}],"balance_after":500000,"derivative":{"exercise_price":2.74,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-22-006624","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222006624/ownership.xml","form_type":"4"}},{"id":2440820,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-01-07T10:32:18.000Z","date":"2022-01-07","kind":"purchase","acquired":true,"shares":20000,"price":3,"value":60000.0,"ownership":{"direct":true},"balance_after":314000,"source":{"system":"sec-edgar","filing":"0001493152-22-000640","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315222000640/ownership.xml","form_type":"4"}},{"id":2531329,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-01T11:05:40.000Z","date":"2021-10-29","kind":"purchase","acquired":true,"shares":2000,"price":4.77,"value":9540.0,"ownership":{"direct":true},"balance_after":294000,"source":{"system":"sec-edgar","filing":"0001493152-21-026828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221026828/ownership.xml","form_type":"4"}},{"id":2624536,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-27T13:08:11.000Z","date":"2021-07-23","kind":"purchase","acquired":true,"shares":5000,"price":4.28,"value":21400.0,"ownership":{"direct":true},"balance_after":292000,"source":{"system":"sec-edgar","filing":"0001493152-21-017833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017833/ownership.xml","form_type":"4"}},{"id":2629755,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-07-20T09:00:20.000Z","date":"2021-07-16","kind":"purchase","acquired":true,"shares":10000,"price":3.94,"value":39400.0,"ownership":{"direct":true},"balance_after":287000,"source":{"system":"sec-edgar","filing":"0001493152-21-017276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221017276/ownership.xml","form_type":"4"}},{"id":2687913,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Award","published_at":"2021-06-02T17:00:15.000Z","date":"2021-05-31","kind":"disposition_to_issuer","acquired":false,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting requirements were not met and the restricted stock award expired on May 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2021-05-31","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001493152-21-013453","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221013453/ownership.xml","form_type":"4"}},{"id":2687912,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-02T17:00:15.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning June 30, 2021."}],"balance_after":500000,"derivative":{"exercise_price":4.02,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-21-013453","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221013453/ownership.xml","form_type":"4"}},{"id":2687911,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-02T17:00:15.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable as follows: (i) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $5.00, (ii) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $6.00, (iii) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $7.00, and (iv) 500,000 shares vest if during any 5 trading day period, the average closing price of the issuer's common stock is at least $8.00."}],"balance_after":2000000,"derivative":{"exercise_price":4.02,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001493152-21-013453","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221013453/ownership.xml","form_type":"4"}},{"id":2772548,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-03-25T13:43:43.000Z","date":"2021-03-25","kind":"purchase","acquired":true,"shares":5000,"price":4.86,"value":24300.0,"ownership":{"direct":true},"balance_after":277000,"source":{"system":"sec-edgar","filing":"0001493152-21-006780","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221006780/ownership.xml","form_type":"4"}},{"id":2889530,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-01T09:00:10.000Z","date":"2021-01-29","kind":"purchase","acquired":true,"shares":10000,"price":3.73,"value":37300.0,"ownership":{"direct":true},"balance_after":272000,"source":{"system":"sec-edgar","filing":"0001493152-21-002176","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315221002176/ownership.xml","form_type":"4"}},{"id":2932106,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-28T18:10:02.000Z","date":"2020-12-23","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning December 31, 2020."}],"balance_after":1000000,"derivative":{"exercise_price":2.83,"expiration_date":"2030-12-23","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-20-024384","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315220024384/ownership.xml","form_type":"4"}},{"id":3033823,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-09-11T11:58:40.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":28000,"price":2.11,"value":59080.0,"ownership":{"direct":true},"balance_after":262000,"source":{"system":"sec-edgar","filing":"0001493152-20-017605","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000149315220017605/ownership.xml","form_type":"4"}},{"id":3112633,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-06-12T10:48:00.000Z","date":"2020-06-12","kind":"purchase","acquired":true,"shares":20000,"price":2.03,"value":40600.0,"ownership":{"direct":true},"balance_after":234000,"source":{"system":"sec-edgar","filing":"0001513162-20-000123","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000123/primary_doc.xml","form_type":"4"}},{"id":3214635,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-12T10:26:50.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":20000,"price":1.82,"value":36400.0,"ownership":{"direct":true},"balance_after":214000,"source":{"system":"sec-edgar","filing":"0001513162-20-000047","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000047/primary_doc.xml","form_type":"4"}},{"id":3312115,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-14T10:47:03.000Z","date":"2020-01-14","kind":"purchase","acquired":true,"shares":20000,"price":2.99,"value":59800.0,"ownership":{"direct":true},"balance_after":194000,"source":{"system":"sec-edgar","filing":"0001513162-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316220000015/primary_doc.xml","form_type":"4"}},{"id":3341695,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-16T17:14:28.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":520000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable in thirty-six (36) equal monthly installments beginning December 31, 2019."}],"balance_after":520000,"derivative":{"exercise_price":3.84,"expiration_date":"2019-12-12","underlying":"Common Stock","underlying_shares":520000},"source":{"system":"sec-edgar","filing":"0001513162-19-000250","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000250/primary_doc.xml","form_type":"4"}},{"id":3409494,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on February 18, 2016 and vested in 36 consecutive monthly installments beginning on March 31, 2016."}],"balance_after":200000,"derivative":{"exercise_price":2.92,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409493,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on February 18, 2016 and vested in 36 consecutive monthly installments beginning on March 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409492,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013."}],"balance_after":40000,"derivative":{"exercise_price":2.575,"expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409491,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409490,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":213333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":213333,"derivative":{"exercise_price":2.575,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409489,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":213333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409488,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":106667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":106667,"derivative":{"exercise_price":2.575,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":106667},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409487,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":106667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":106667},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409486,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"grant","acquired":true,"shares":320000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on September 19, 2012 and vested in 36 equal monthly installments beginning on October 31, 2012."}],"balance_after":320000,"derivative":{"exercise_price":2.575,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3409485,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2019-09-20T17:37:48.000Z","date":"2019-09-20","kind":"disposition_to_issuer","acquired":false,"shares":320000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options due to a settlement pursuant to which these options that had been repriced on September 6, 2017 to $0.67, would have their exercise price changed to the exercise price immediately prior to that repricing, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on September 19, 2012 and vested in 36 equal monthly installments beginning on October 31, 2012."}],"balance_after":0,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001513162-19-000212","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/primary_doc.xml","form_type":"4"}},{"id":3414490,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-16T10:00:09.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":10000,"price":4.12,"value":41200.0,"ownership":{"direct":true},"balance_after":174000,"source":{"system":"sec-edgar","filing":"0001513162-19-000206","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000206/primary_doc.xml","form_type":"4"}},{"id":3547097,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-29T08:58:53.000Z","date":"2019-04-26","kind":"purchase","acquired":true,"shares":4000,"price":4.21,"value":16840.0,"ownership":{"direct":true},"balance_after":164000,"source":{"system":"sec-edgar","filing":"0001513162-19-000114","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000114/primary_doc.xml","form_type":"4"}},{"id":3550673,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-24T13:44:51.000Z","date":"2019-04-24","kind":"purchase","acquired":true,"shares":10000,"price":4.27,"value":42700.0,"ownership":{"direct":true},"balance_after":160000,"source":{"system":"sec-edgar","filing":"0001513162-19-000111","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316219000111/primary_doc.xml","form_type":"4"}},{"id":3783734,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-10-25T12:42:02.000Z","date":"2018-10-25","kind":"purchase","acquired":true,"shares":11000,"price":3.9,"value":42900.0,"ownership":{"direct":true},"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001513162-18-000267","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000267/primary_doc.xml","form_type":"4"}},{"id":3813695,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-09-18T11:19:03.000Z","date":"2018-09-14","kind":"purchase","acquired":true,"shares":3000,"price":4.08,"value":12240.0,"ownership":{"direct":true},"balance_after":139000,"source":{"system":"sec-edgar","filing":"0001513162-18-000235","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000235/primary_doc.xml","form_type":"4"}},{"id":3816538,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-09-14T09:54:13.000Z","date":"2018-09-13","kind":"purchase","acquired":true,"shares":3000,"price":3.84,"value":11520.0,"ownership":{"direct":true},"balance_after":136000,"source":{"system":"sec-edgar","filing":"0001513162-18-000233","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000233/primary_doc.xml","form_type":"4"}},{"id":3817576,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-09-13T12:49:25.000Z","date":"2018-09-13","kind":"purchase","acquired":true,"shares":4112,"price":3.96,"value":16283.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.951 to $3.9646, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":133000,"source":{"system":"sec-edgar","filing":"0001513162-18-000232","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000232/primary_doc.xml","form_type":"4"}},{"id":3819006,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-09-12T19:13:03.000Z","date":"2018-09-12","kind":"purchase","acquired":true,"shares":4480,"price":3.99,"value":17875.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.9886 to $3.993, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":128888,"source":{"system":"sec-edgar","filing":"0001513162-18-000231","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000231/primary_doc.xml","form_type":"4"}},{"id":3936256,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2018-05-14T20:44:57.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable as follows: (i) 500,000 shares vest if during any 20 trading day period on or before May 31, 2021, the average closing stock price of the issuers common stock is at least $5.00, (ii) 500,000 shares vest if during any 20 trading day period on or before May 31, 2021, the average closing stock price of the issuers common stock is at least $7.00, and (iii) 500,000 shares vest if during any 20 trading day period on or before May 31, 2021, the average closing stock price of the issuers common stock is at least $8.00"}],"balance_after":1500000,"derivative":{"exercise_price":3.7,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001513162-18-000125","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000125/primary_doc.xml","form_type":"4"}},{"id":3936255,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2018-05-14T20:44:57.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in equal installments on a monthly basis over three years beginning on May 31, 2018."}],"balance_after":600000,"derivative":{"exercise_price":3.7,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001513162-18-000125","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000125/primary_doc.xml","form_type":"4"}},{"id":3936254,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Award","published_at":"2018-05-14T20:44:57.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":1500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock award vests in its entirety if during any 20 trading day period on or before May 31, 2021 in which the reporting person is employed by the issuer, the average closing stock price of the issuers common stock is at least $11.00."}],"balance_after":1500000,"derivative":{"exercise_price":0,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":1500000},"source":{"system":"sec-edgar","filing":"0001513162-18-000125","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316218000125/primary_doc.xml","form_type":"4"}},{"id":4214191,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on February 18, 2016 and vested in 36 consecutive monthly installments beginning on March 31, 2016."}],"balance_after":200000,"derivative":{"exercise_price":0.67,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214190,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was originally granted on February 18, 2016 and vested in 36 consecutive monthly installments beginning on March 31, 2016."}],"balance_after":0,"derivative":{"exercise_price":2.92,"expiration_date":"2026-02-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214189,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013."}],"balance_after":40000,"derivative":{"exercise_price":0.67,"expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214188,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013."}],"balance_after":0,"derivative":{"exercise_price":2.575,"expiration_date":"2023-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214187,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":213333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":213333,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214186,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":213333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":0,"derivative":{"exercise_price":2.575,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":213333},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214185,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":106667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":106667,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":106667},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214184,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":106667,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was originally granted September 19, 2012 and vested as follows: (i) 106,667 shares upon the achievement of certain performance criteria; and (ii) 213,333 shares in two equal installments if the average closing price of the Company's common stock exceeds certain specified levels."}],"balance_after":0,"derivative":{"exercise_price":2.575,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":106667},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214183,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":320000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on September 19, 2012 and vested in 36 equal monthly installments beginning on October 31, 2012."}],"balance_after":320000,"derivative":{"exercise_price":0.67,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4214182,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option","published_at":"2017-09-08T17:59:23.000Z","date":"2017-09-06","kind":"disposition_to_issuer","acquired":false,"shares":320000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the \"old\" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was originally granted on September 19, 2012 and vested in 36 equal monthly installments beginning on October 31, 2012."}],"balance_after":0,"derivative":{"exercise_price":2.575,"expiration_date":"2022-09-19","underlying":"Common Stock","underlying_shares":320000},"source":{"system":"sec-edgar","filing":"0001513162-17-000253","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000253/primary_doc.xml","form_type":"4"}},{"id":4291985,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-06T11:11:23.000Z","date":"2017-06-05","kind":"purchase","acquired":true,"shares":10000,"price":0.9,"value":9000.0,"ownership":{"direct":true},"balance_after":124408,"source":{"system":"sec-edgar","filing":"0001513162-17-000184","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000184/primary_doc.xml","form_type":"4"}},{"id":4294533,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T10:39:33.000Z","date":"2017-06-02","kind":"purchase","acquired":true,"shares":8078,"price":0.88,"value":7108.64,"ownership":{"direct":true},"balance_after":114408,"source":{"system":"sec-edgar","filing":"0001513162-17-000182","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000182/primary_doc.xml","form_type":"4"}},{"id":4294532,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T10:39:33.000Z","date":"2017-06-02","kind":"purchase","acquired":true,"shares":1422,"price":0.87,"value":1237.14,"ownership":{"direct":true},"balance_after":106330,"source":{"system":"sec-edgar","filing":"0001513162-17-000182","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000182/primary_doc.xml","form_type":"4"}},{"id":4294531,"issuer":{"id":6698,"kind":"organization","name":"Anixa Biosciences Inc","symbol":"ANIX"},"owners":[{"id":27361,"kind":"person","name":"KUMAR AMIT","position":1,"cik":"0001191905","reported_name":"KUMAR AMIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T10:39:33.000Z","date":"2017-06-02","kind":"purchase","acquired":true,"shares":500,"price":0.86,"value":430.0,"ownership":{"direct":true},"balance_after":104908,"source":{"system":"sec-edgar","filing":"0001513162-17-000182","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/715446/000151316217000182/primary_doc.xml","form_type":"4"}}]}